Federated Hermes’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.76K Buy
2024
Q1
Sell
2023
Q4
$1.11M Hold
2023
Q3
$2.16M Sell
2023
Q2
$3.95M Sell
2023
Q1
$7.79M Sell
2022
Q4
$9.48M Buy